Overview


The at-home diagnostic market comprises medical tests and kits that enable individuals to monitor their health at home. This includes tests such as COVID-19 kits, blood sugar monitors, pregnancy tests, and DNA tests. The market is experiencing rapid growth due to the convenience it offers, rising health awareness, and technological advancements that have made testing accurate, fast, and easy without the need to visit a clinic.

According to FutureWise analysis, the at-home diagnostics market in 2026 is US$7.03 billion, and is expected to reach US$11.28 billion by 2036 at a CAGR of 4.84%. The steady growth of the at-home diagnostics market is driven by several factors, including increasing consumer preference for convenient healthcare solutions and the rising prevalence of chronic diseases that require regular monitoring. This market is further fueled by technological advancements in portable testing devices, enhanced accuracy of rapid test kits, and a growing focus on preventive healthcare, particularly among aging populations.

Growth Drivers:

  • Increased Health Awareness: People are becoming more proactive about monitoring their health at home.
  • Convenience and Accessibility: Easy-to-use kits save time and reduce the need for clinic visits.
  • Technological advancements, including improved accuracy, faster results, and user-friendly devices, enhance the testing experience.
  • Rise in Chronic Diseases: The increasing prevalence of diabetes, heart disease, and other conditions drives up demand for at-home testing.
  • Impact of the COVID-19 Pandemic: There has been a surge in demand for at-home testing, especially for COVID-19 kits.

Key Trends:

  • Rise of Connected & Smart Devices: Home diagnostic tools are integrating with mobile apps and digital platforms for real-time health tracking.
  • Growth in Telemedicine Integration: At-home diagnostics allow data sharing with doctors and support remote consultations.
  • Focus on Chronic & Preventive Health Monitoring: Increasing demand for tests to monitor conditions like diabetes and heart health at home.
  • Innovation in Self-Testing Kits: Launch of more accurate, user-friendly, and multi-functional rapid test kits.

Market Segmentation and Key Players:

The at-home diagnostics market is segmented by test type (like glucose tests, pregnancy tests, infectious disease tests, drug abuse tests, ovulation tests, and cholesterol tests), by product type (such as cassettes, strips, midstream kits, and panels), by sample type (blood, urine, saliva, serum), by distribution channel (retail pharmacies, drug stores, supermarkets/hypermarkets, online pharmacies), and by region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa). This structure helps companies and stakeholders understand demand across different testing needs, product formats, sample methods, sales channels, and geographic markets. Comprehensive segmentation details are provided in the Segmentation section below.

Major companies operating in the At Home Diagnostics Market include Abbott Laboratories and F. Hoffmann-La Roche Ltd.

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Chembio Diagnostics, Inc.
  • Quidel Corp
  • Nectar Lifesciences Ltd (Rapikit) 
  • Bionime Corp
  • Becton, Dickinson & Co.
  • PRIMA Lab
  • Atlas Medical UK  
  • OraSure Technologies
  • B. Braun Melsungen AG
  • Lifescan Inc
  • Troge Medical Gmbh
  • Nova Biomedical
  • Siemens Healthcare
  • Cardinal Health, Inc
  • EmsiG GmbH  Co
  •  Acon Laboratories Inc.
  • Trividia Health, Inc.
  • TaiDoc Technology Corporation

Recent developments by key players in the Global At-Home Diagnostics Market:

Becton, Dickinson & Co. (BD)

  • BD has announced a strategic merger valued at $17.5 billion with the biosciences and diagnostics division of Waters Corporation. This merger aims to enhance BD's position in the diagnostics market by improving its capabilities in bioseparations, bioanalytical characterization, and multiplex diagnostics. The newly formed entity is projected to generate $6.5 billion in revenue by 2025, with expected annual cost savings of $345 million by 2030.
  • In mid-2024, BD partnered with Healthians in India to launch at-home self-collection kits for cervical cancer screening. This initiative enables women to collect HPV samples from home and receive extended genotyping results, significantly improving screening uptake in underserved populations.

Abbott Laboratories

  • Holds approximately 20% of the market share in at-home diagnostics and has recently launched more affordable and connected continuous glucose monitoring (CGM) systems, such as Libre Rio and Lingo, with enhanced mobile integration and real-time data transmission for diabetes self-management.

Quidel Corp

  • Expanded its portfolio by introducing rapid at-home antigen tests, including for influenza, to align with the growing consumer demand for convenient self-testing tools.

In April 2021, to enhance access to HIV self-testing in Low and Middle-Income Countries, Viatris and Atomo Diagnostics committed to working with Unitaid, with an aim to make HIV testing available in 135 countries. The Unitaid expansion programme financed the distribution of up to 1 million HIV self-test kits.

The global at-home diagnostic market is a rapidly growing industry driven by various factors, such as the increasing incidence of chronic illnesses, rising awareness about preventive healthcare, technological advancements, and the growing demand for personalized medicine. The COVID-19 pandemic has influenced the growth of this market as people have become more cautious about visiting hospitals and clinics, leading to a higher demand for at-home diagnostic tests. One of the major factors driving the expansion of the at-home diagnostic market is the increasing prevalence of chronic disorders including diabetes, cancer, cardiovascular diseases, and respiratory diseases. The availability of at-home diagnostic tests allows patients to monitor their health regularly, which can help in early detection of these diseases and prevent further complications. Moreover, there is a growing trend of people taking control of their health and being proactive about preventative care. At-home diagnostic tests provide a convenient and accessible way to monitor one's health without regular visits to healthcare facilities.

Furthermore, the demand for personalized medicine has also driven the growth of the at-home diagnostic market. At-home diagnostic tests can provide a more customized approach to healthcare by allowing patients to monitor their health more closely and tailor their treatment plans accordingly. However, the global at-home diagnostic market faces restraints that could hinder its growth. These restraints include a lack of standardization, regulatory challenges, limited test accuracy, limited availability of advanced tests, and limited reimbursement. Despite these challenges, the market is expected to continue to grow in the forecast period.

By Test Type

  • Glucose Tests
  • Pregnancy Test
  • Infections Disease Test
    • HIV Test
    • Urinary and Genital Infection
    • Others
  • Drug Abuse Test
  • Ovulation Predictor Test
    • Ovulation-LH Test
    • Menopause-FSH Test
    • Sperm Test   
  • Cholesterol and Triglycerides Tests
  • Other Test Type

By Type

  • Cassette
  • Strip
  • Midstream
  • Test Panel
  • Dip Card
  • Others

By Sample Type

  • Blood
  • Urine
  • Saliva
  • Serum
  • Others

By Distribution Channel

  • Retail Pharmacies
  • Drug Stores
  • Supermarket/Hypermarket
  • Online Pharmacies

By Region

  • North America 
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

Here’s a regional view of where the most progress is happening 

North America leads the At-Home Diagnostics Market, holding the largest share due to its advanced healthcare systems, strong research and development, and high levels of consumer adoption.

Europe closely trails with its solid healthcare policies and innovative practices.

 The Asia Pacific region is witnessing the most rapid growth and development, fueled by its substantial population, increasing healthcare awareness, a growing middle class, and government initiatives that promote digital and remote diagnostics.

Meanwhile, Latin America and the Middle East & Africa are emerging markets that are demonstrating gradual yet encouraging adoption.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America dominated the worldwide global at home diagnostics market and is expected to maintain its dominance in the years to come. In 2020, the U.S. held a market share of almost 90% in North America. This is a result of rising healthcare spending per person. The amount spent on healthcare per person in the US in 2020 was reported to be approximately $10,264. In addition, rising chronic illness occurrences, higher consumer awareness of home diagnostics, expanding geriatric populations, and increased consumer disposable income all played a significant role in the market's expansion in North America. Additionally, on a global scale, based on type; cassettes hold highest market share of 38.9%, followed by strips holding a market share of 24.7% in 2022.

  • Tier 1 players- established companies in the market with major market share
  • Tier 2 players
  • New Entrants
  • Emerging players which are growing rapidly

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data points affecting market growth

  • To provide with an exhaustive analysis on the of Global At Home Diagnostics Market By Test Type, By Type, By Sample Type, By Distribution Channel and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   At Home Diagnostics Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of At Home Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   At Home Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   At Home Diagnostics Market, By Test Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Glucose Tests
        2. Pregnancy Test
        3. Infections Disease Test
         3.1. HIV Test
         3.2. Urinary and Genital Infection
         3.3. Others
        4. Drug Abuse Test
        5. Ovulation Predictor Test
         5.1 . Ovulation-LH Test
         5.2 . Menopause-FSH Test
         5.3 . Sperm Test
        6. Cholesterol and Triglycerides Tests
        7. Other Test Type

  • 8.   At Home Diagnostics Market, By Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Cassette
        2. Strip
        3. Midstream
        4. Test Panel
        5. Dip Card
        6. Others

  • 9.  At Home Diagnostics Market, By Sample Type Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Urine
        2. Blood
        3. Saliva
        4. Serum
        5. Others

  • 10.  At Home Diagnostics Market, By Distribution Channel Historical Analysis and Forecast 2026-2036 (USD Million)

    •   1. Retail Pharmacies
        2. Drug Store
        3. Supermarket/Hypermarket
        4. Online Pharmacies

  • 11.   North America At Home Diagnostics Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 12.   Latin America At Home Diagnostics Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 13.   Europe At Home Diagnostics Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 14.   Asia Pacific At Home Diagnostics Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 15.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Abbott Laboratories
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. F. Hoffmann-La Roche Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Chembio Diagnostics, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Quidel Corp
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Nectar Lifesciences Ltd (Rapikit)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bionime Corp
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Becton, DickinsonCo.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. PRIMA Lab
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Atlas Medical UK
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. OraSure Technologies
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. B. Braun Melsungen AG
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Lifescan Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Troge Medical Gmbh
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Nova Biomedical
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Siemens Healthcare
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Cardinal Health, Inc
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. EmsiG GmbH Co
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Acon Laboratories Inc.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Trividia Health, Inc.
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. TaiDoc Technology Corporation
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

FAQ


Our market forecast takes into account a variety of factors to provide the most comprehensive analysis. These include:

  • Current market trends and future predictions.
  • Technological advancements impacting at-home testing kits.
  • Regulatory policies and their influence on market dynamics.
  • The impact of global health situations on the demand for at-home diagnostics.
  • Consumer behavior and preferences towards home-based healthcare.
  • Competitive landscape and key market players' strategies.
  • Economic indicators and their effect on market growth.

Yes, our market forecast incorporates emerging trends in the health-tech industry that are likely to influence the at-home diagnostics market. This ensures that readers stay informed about the latest innovations and their potential impacts on the market.

Challenges encompass regulatory obstacles, apprehensions regarding the accuracy of tests, issues related to data privacy, and a lack of awareness in developing areas.

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 113 519 7222
  • US : +1 347 709 4931

Related Market

At-Home Fetal Dopplers Market

Read More

At-Home Drug of Abuse Market

Read More

At-Home Cancer Testing Market

Read More

At-Home Testing Kits Market

Read More

At-Home Vaginal pH test Kit Market

Read More

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11